摘要
目的:研究曲安奈德联合利多卡因通过痛点注射对慢性腰肌劳损康复治疗的临床效果以及对患者血清炎性因子水平的影响。方法:2020年10月-2020年12月收治慢性腰肌劳损患者58例,随机分为两组,各29例。对照组给予利多卡因通过痛点注射治疗;研究组给予曲安奈德联合利多卡因通过痛点注射治疗。比较两组治疗效果及血清炎性因子水平。结果:研究组治疗总有效率高于对照组,差异有统计学意义(P<0.05);研究组治疗后肿瘤坏死因子(TNF)-α、白介素6(IL-6)及血栓素B2(TXB2)水平均低于对照组,6-酮-前列腺素Fla(6-Keto-PGFla)水平高于对照组,差异均有统计学意义(P<0.05)。结论:应用曲安奈德联合利多卡因通过痛点注射对慢性腰肌劳损患者的康复治疗有明显临床疗效,能够减轻患者腰部疼痛,减轻局部炎性反应。
Objective:To explore the clinical efficacy of triamcinolone acetonide combined with lidocaine injection through pain points in the rehabilitation of chronic lumbar muscle strain and its effect on the level of serum inflammatory factors.Methods:From October 2020 to December 2020,58 patients with chronic lumbar muscle strain were selected.They were randomly divided into two groups with 29 cases in each group.The control group was treated with lidocaine through pain point injection.The study group was treated with triamcinolone acetonide combined with lidocaine through pain point injection.The therapeutic effect and the level of serum inflammatory factors were compared between the two groups.Results:The total effective rate of the study group was significantly higher than that of the control group,the difference was statistically significant(P<0.05).In the study group,after treatment,the levels of tumor necrosis factor(TNF-α),interleukin-6(IL-6)and thromboxane B2(TXB2)were significantly lower than those in the control group,and the levels of 6-keto-pgfla were significantly higher than those in the control group,the difference was statistically significant(P<0.05).Conclusion:The clinical efficacy of triamcinolone acetonide combined with lidocaine injection through pain points in the rehabilitation of chronic lumbar muscle strain is significant,it can reduce patients'waist pain and local inflammatory reaction.
作者
田前刚
Tian Qiangang(Department of Rehabilitation Medicine,Humen Hospital of Traditional Chinese Medicine,Guangdong Dongguan 523900)
出处
《中国社区医师》
2021年第31期37-38,共2页
Chinese Community Doctors
关键词
曲安奈德
利多卡因
痛点注射
临床疗效
血清
Triamcinolone acetonide
Lidocaine
Pain point injection
Clinical efficacy
Serum
